Vaxcyte

YTD

ALL

Trade Vaxcyte 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PCVX

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.

CEO

Grant E. Pickering

CEOGrant E. Pickering

Employees

414

Employees414

Headquarters

San Carlos, California

HeadquartersSan Carlos, California

Founded

2013

Founded2013

Employees

414

Employees414

PCVX Key Statistics

Market cap

4.72B

Market cap4.72B

Price-Earnings ratio

-8.99

Price-Earnings ratio-8.99

Dividend yield

—

Dividend yield—

Average volume

2.45M

Average volume2.45M

High today

—

High today—

Low today

—

Low today—

Open price

$32.01

Open price$32.01

Volume

786.00

Volume786.00

52 Week high

$121.06

52 Week high$121.06

52 Week low

$27.66

52 Week low$27.66

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own PCVX. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Vaxcyte

Trade Vaxcyte 24 hours a day, five days a week on Robinhood.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. Show more

PCVX Key Statistics

Analyst ratings

100%

People also own

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.